Cyclophilin A: a Key Player for Human Disease

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2013 Nov 2

PMID 24176846

Citations 218

Authors

P Nigro

G Pompilio

M C Capogrossi

Affiliations

Soon will be listed here.

Abstract

Cyclophilin A (CyPA) is a ubiquitously distributed protein belonging to the immunophilin family. CyPA has peptidyl prolyl cis-trans isomerase (PPIase) activity, which regulates protein folding and trafficking. Although CyPA was initially believed to function primarily as an intracellular protein, recent studies have revealed that it can be secreted by cells in response to inflammatory stimuli. Current research in animal models and humans has provided compelling evidences supporting the critical function of CyPA in several human diseases. This review discusses recently available data about CyPA in cardiovascular diseases, viral infections, neurodegeneration, cancer, rheumatoid arthritis, sepsis, asthma, periodontitis and aging. It is believed that further elucidations of the role of CyPA will provide a better understanding of the molecular mechanisms underlying these diseases and will help develop novel pharmacological therapies.

Citing Articles

Exploration of the Role of Cyclophilins in Established Hepatitis B and C Infections.

Molle J, Duponchel S, Rieusset J, Ovize M, Ivanov A, Zoulim F Viruses. 2025; 17(1.

PMID: 39861799 PMC: 11768883. DOI: 10.3390/v17010011.

Macrocyclic peptides as a new class of targeted protein degraders.

Jing X, Mackay J, Passioura T RSC Chem Biol. 2025; 6(3):326-337.

PMID: 39822773 PMC: 11733494. DOI: 10.1039/d4cb00199k.

Differential Expression of Neurodegeneration-Related Genes in SH-SY5Y Neuroblastoma Cells Under the Influence of Cyclophilin A: Could the Enzyme be a Likely Trigger and Therapeutic Target for Alzheimer's Disease?.

Pashaei S, Shabani S, Mohammadi S, Morozova-Roche L, Salari N, Rahimi Z Neurochem Res. 2024; 50(1):47.

PMID: 39636462 DOI: 10.1007/s11064-024-04253-2.

Toward Dual Targeting of Catalytic and Gatekeeper Pockets in Cyclophilins Using a Macrocyclic Scaffold.

Dreizler J, Meyners C, Hausch F ACS Med Chem Lett. 2024; 15(11):2012-2018.

PMID: 39563809 PMC: 11571008. DOI: 10.1021/acsmedchemlett.4c00427.

Flotillin-2 dampens T cell antigen sensitivity and functionality.

Moon S, Zhao F, Uddin M, Tucker C, Karmaus P, Fessler M JCI Insight. 2024; 9(24).

PMID: 39499901 PMC: 11665568. DOI: 10.1172/jci.insight.182328.

References

Nigro P, Satoh K, ODell M, Soe N, Cui Z, Mohan A . Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice. J Exp Med. 2010; 208(1):53-66. PMC: 3023134. DOI: 10.1084/jem.20101174. View

Griendling K, FitzGerald G . Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation. 2003; 108(16):1912-6. DOI: 10.1161/01.CIR.0000093660.86242.BB. View

Howard B, Furumai R, Campa M, Rabbani Z, Vujaskovic Z, Wang X . Stable RNA interference-mediated suppression of cyclophilin A diminishes non-small-cell lung tumor growth in vivo. Cancer Res. 2005; 65(19):8853-60. DOI: 10.1158/0008-5472.CAN-05-1219. View

Wang C, Dai J, Wang L, Jia J, Zheng Z, Ding J . Expression of CD147 (EMMPRIN) on neutrophils in rheumatoid arthritis enhances chemotaxis, matrix metalloproteinase production and invasiveness of synoviocytes. J Cell Mol Med. 2010; 15(4):850-60. PMC: 3922672. DOI: 10.1111/j.1582-4934.2010.01084.x. View

Liu L, Li C, Xiang J, Dong W, Cao Z . Over-expression and potential role of cyclophilin A in human periodontitis. J Periodontal Res. 2013; 48(5):615-22. DOI: 10.1111/jre.12047. View

Borel J, Feurer C, Magnee C, STAHELIN H . Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology. 1977; 32(6):1017-25. PMC: 1445439. View

Seizer P, Ochmann C, Schonberger T, Zach S, Rose M, Borst O . Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion. Arterioscler Thromb Vasc Biol. 2011; 31(6):1377-86. PMC: 3113549. DOI: 10.1161/ATVBAHA.111.225771. View

Mittal N, Voldman J . Nonmitogenic survival-enhancing autocrine factors including cyclophilin A contribute to density-dependent mouse embryonic stem cell growth. Stem Cell Res. 2010; 6(2):168-76. PMC: 3077536. DOI: 10.1016/j.scr.2010.10.001. View

Kanyenda L, Verdile G, Boulos S, Krishnaswamy S, Taddei K, Meloni B . The dynamics of CD147 in Alzheimer's disease development and pathology. J Alzheimers Dis. 2011; 26(4):593-605. DOI: 10.3233/JAD-2011-110584. View

10.

Mori T, Itami S, Yanagi T, Tatara Y, Takamiya M, Uchida T . Use of a real-time fluorescence monitoring system for high-throughput screening for prolyl isomerase inhibitors. J Biomol Screen. 2009; 14(4):419-24. DOI: 10.1177/1087057109333979. View

11.

Gromov P, Skovgaard G, Palsdottir H, Gromova I, Ostergaard M, Celis J . Protein profiling of the human epidermis from the elderly reveals up-regulation of a signature of interferon-gamma-induced polypeptides that includes manganese-superoxide dismutase and the p85beta subunit of phosphatidylinositol 3-kinase. Mol Cell Proteomics. 2003; 2(2):70-84. DOI: 10.1074/mcp.M200051-MCP200. View

12.

Chen S, Zhang M, Ma H, Saiyin H, Shen S, Xi J . Oligo-microarray analysis reveals the role of cyclophilin A in drug resistance. Cancer Chemother Pharmacol. 2007; 61(3):459-69. DOI: 10.1007/s00280-007-0491-y. View

13.

Chatterji U, Bobardt M, Selvarajah S, Yang F, Tang H, Sakamoto N . The isomerase active site of cyclophilin A is critical for hepatitis C virus replication. J Biol Chem. 2009; 284(25):16998-17005. PMC: 2719337. DOI: 10.1074/jbc.M109.007625. View

14.

Helekar S, Patrick J . Peptidyl prolyl cis-trans isomerase activity of cyclophilin A in functional homo-oligomeric receptor expression. Proc Natl Acad Sci U S A. 1997; 94(10):5432-7. PMC: 24696. DOI: 10.1073/pnas.94.10.5432. View

15.

LUBAN J . Absconding with the chaperone: essential cyclophilin-Gag interaction in HIV-1 virions. Cell. 1996; 87(7):1157-9. DOI: 10.1016/s0092-8674(00)81811-5. View

16.

Satoh K, Nigro P, Zeidan A, Soe N, Jaffre F, Oikawa M . Cyclophilin A promotes cardiac hypertrophy in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2011; 31(5):1116-23. PMC: 3085960. DOI: 10.1161/ATVBAHA.110.214601. View

17.

Basso M, Samengo G, Nardo G, Massignan T, DAlessandro G, Tartari S . Characterization of detergent-insoluble proteins in ALS indicates a causal link between nitrative stress and aggregation in pathogenesis. PLoS One. 2009; 4(12):e8130. PMC: 2780298. DOI: 10.1371/journal.pone.0008130. View

18.

Qi Y, He Q, Ma Y, Du Y, Liu G, Li Y . Proteomic identification of malignant transformation-related proteins in esophageal squamous cell carcinoma. J Cell Biochem. 2008; 104(5):1625-35. DOI: 10.1002/jcb.21727. View

19.

Liu L, Li C, Cai C, Xiang J, Cao Z . Cyclophilin A (CypA) is associated with the inflammatory infiltration and alveolar bone destruction in an experimental periodontitis. Biochem Biophys Res Commun. 2009; 391(1):1000-6. DOI: 10.1016/j.bbrc.2009.12.005. View

20.

Piechota-Polanczyk A, Demyanets S, Nykonenko O, Huk I, Mittlboeck M, Domenig C . Decreased tissue levels of cyclophilin A, a cyclosporine a target and phospho-ERK1/2 in simvastatin patients with abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2013; 45(6):682-8. DOI: 10.1016/j.ejvs.2013.02.015. View